Treatment Options for Nonmetastatic CRPC
Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.
Source: curetoday.com
Prosper Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Prosper Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Prosper Trial Today - Breaking & Trending Today
Scenario 3: A 44-Year-Old Woman With RCC at Intermediate-High Risk for Recurrence
Expert panelists highlight aspects of a final patient scenario, discussing adjuvant treatment strategies in the setting of renal cell carcinoma at intermediate-high risk for recurrence.
Source: onclive.com
Importance of Quality of Life When Choosing Therapy for nmCRPC
A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.
Source: onclive.com
AR Inhibitors in nmCRPC: Real-World Data
Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com
nmCRPC: Clinical Trial Data on AR Inhibitors
Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.
Source: onclive.com